110 related articles for article (PubMed ID: 32079634)
1. Draft Genome Sequence of Adlercreutzia equolifaciens IPLA 37004, a Human Intestinal Strain That Does Not Produce Equol from Daidzein.
Vázquez L; Flórez AB; Mayo B
Microbiol Resour Announc; 2020 Feb; 9(8):. PubMed ID: 32079634
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of Soy Isoflavones by Intestinal Bacteria: Genome Analysis of an
Vázquez L; Flórez AB; Redruello B; Mayo B
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32586036
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional Regulation of the Equol Biosynthesis Gene Cluster in
Flórez AB; Vázquez L; Rodríguez J; Redruello B; Mayo B
Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052328
[TBL] [Abstract][Full Text] [Related]
4. Heterologous expression of equol biosynthesis genes from Adlercreutzia equolifaciens.
Vázquez L; Flórez AB; Rodríguez J; Mayo B
FEMS Microbiol Lett; 2021 Jul; 368(13):. PubMed ID: 34173644
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of inter-individual differences in gut bacterial isoflavone bioactivation in humans by PCR-based targeting of genes involved in equol formation.
Braune A; Blaut M
J Appl Microbiol; 2018 Jan; 124(1):220-231. PubMed ID: 29055162
[TBL] [Abstract][Full Text] [Related]
6. Development and Use of a Real-Time Quantitative PCR Method for Detecting and Quantifying Equol-Producing Bacteria in Human Faecal Samples and Slurry Cultures.
Vázquez L; Guadamuro L; Giganto F; Mayo B; Flórez AB
Front Microbiol; 2017; 8():1155. PubMed ID: 28713336
[TBL] [Abstract][Full Text] [Related]
7. Complete Genome Sequence of the Equol-Producing Bacterium Adlercreutzia equolifaciens DSM 19450T.
Toh H; Oshima K; Suzuki T; Hattori M; Morita H
Genome Announc; 2013 Sep; 1(5):. PubMed ID: 24051320
[TBL] [Abstract][Full Text] [Related]
8. Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production.
Iino C; Shimoyama T; Iino K; Yokoyama Y; Chinda D; Sakuraba H; Fukuda S; Nakaji S
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30791484
[TBL] [Abstract][Full Text] [Related]
9. Compositional and functional differences in human gut microbiome with respect to equol production and its association with blood lipid level: a cross-sectional study.
Zheng W; Ma Y; Zhao A; He T; Lyu N; Pan Z; Mao G; Liu Y; Li J; Wang P; Wang J; Zhu B; Zhang Y
Gut Pathog; 2019; 11():20. PubMed ID: 31168326
[TBL] [Abstract][Full Text] [Related]
10. Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects.
Mayo B; Vázquez L; Flórez AB
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31527435
[TBL] [Abstract][Full Text] [Related]
11. Complete Genome Sequence of Adlercreutzia equolifaciens subsp.
Takahashi H; Yang J; Yamamoto H; Fukuda S; Arakawa K
Microbiol Resour Announc; 2021 May; 10(19):. PubMed ID: 33986097
[No Abstract] [Full Text] [Related]
12. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.
Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126
[TBL] [Abstract][Full Text] [Related]
13. Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella.
Maruo T; Sakamoto M; Ito C; Toda T; Benno Y
Int J Syst Evol Microbiol; 2008 May; 58(Pt 5):1221-7. PubMed ID: 18450717
[TBL] [Abstract][Full Text] [Related]
14. Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol.
Jin JS; Kitahara M; Sakamoto M; Hattori M; Benno Y
Int J Syst Evol Microbiol; 2010 Aug; 60(Pt 8):1721-1724. PubMed ID: 19734283
[TBL] [Abstract][Full Text] [Related]
15. High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart.
Frankenfeld CL; Atkinson C; Thomas WK; Gonzalez A; Jokela T; Wähälä K; Schwartz SM; Li SS; Lampe JW
Br J Nutr; 2005 Dec; 94(6):873-6. PubMed ID: 16351761
[TBL] [Abstract][Full Text] [Related]
16. Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries.
Jackman KA; Woodman OL; Chrissobolis S; Sobey CG
Brain Res; 2007 Apr; 1141():99-107. PubMed ID: 17274967
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.
Reverri EJ; Slupsky CM; Mishchuk DO; Steinberg FM
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27364093
[TBL] [Abstract][Full Text] [Related]
18. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.
Atkinson C; Frankenfeld CL; Lampe JW
Exp Biol Med (Maywood); 2005 Mar; 230(3):155-70. PubMed ID: 15734719
[TBL] [Abstract][Full Text] [Related]
19. Effect of Soy Isoflavones on Growth of Representative Bacterial Species from the Human Gut.
Vázquez L; Flórez AB; Guadamuro L; Mayo B
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698467
[TBL] [Abstract][Full Text] [Related]
20. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.
Liu ZM; Ho SC; Chen YM; Ho S; To K; Tomlinson B; Woo J
Mol Nutr Food Res; 2014 Apr; 58(4):709-17. PubMed ID: 24273218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
